{
  "event_id": "38cfe8527d24",
  "ticker": "HCM",
  "company_name": "HUTCHMED",
  "drug_name": "Surufatinib",
  "pdufa_date": "2022-04-30",
  "approval_type": {
    "status": "found",
    "value": "nda",
    "source": "websearch:SANET-ep/p Phase 3 (China 2020-2021)",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T19:13:38.466186",
    "error": null
  },
  "indication": {
    "status": "found",
    "value": "Neuroendocrine tumors (China approved; US CRL)",
    "source": "websearch:SANET-ep/p Phase 3 (China 2020-2021)",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T19:13:38.466188",
    "error": null
  },
  "generic_name": {
    "status": "found",
    "value": "surufatinib",
    "source": "websearch_fda",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T07:18:32.440880",
    "error": null
  },
  "therapeutic_area": {
    "status": "found",
    "value": "Oncology",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T10:49:58.784249",
    "error": null
  },
  "phase": {
    "status": "found",
    "value": "CRL",
    "source": "websearch_clinical",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T07:18:32.440880",
    "error": null
  },
  "primary_endpoint_met": {
    "status": "found",
    "value": true,
    "source": "websearch:SANET-ep/p Phase 3 (China 2020-2021)",
    "confidence": 0.95,
    "evidence": [
      "SANET-ep/p Phase 3 (China 2020-2021)"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T19:13:38.466173",
    "error": null
  },
  "p_value": {
    "status": "found",
    "value": "<0.0001",
    "source": "websearch:SANET-ep/p Phase 3 (China 2020-2021)",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T19:13:38.466180",
    "error": null
  },
  "p_value_numeric": 0.0001,
  "effect_size": {
    "status": "found",
    "value": "PFS HR 0.33 (SANET-ep); HR 0.49 (SANET-p)",
    "source": "websearch:SANET-ep/p Phase 3 (China 2020-2021)",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T19:13:38.466183",
    "error": null
  },
  "safety_signal": {
    "status": "found",
    "value": false,
    "source": "derived_from_crl_reason",
    "confidence": 0.85,
    "tier": 2
  },
  "phase3_study_names": [
    "A Multi-Center, Open-Label, Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Surufatinib (HMPL-012), Previously Named Sulfatinib in Advanced Solid Tumors"
  ],
  "nct_ids": [
    "NCT02549937"
  ],
  "enrollment": {
    "value": 130,
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2
  },
  "has_prior_crl": {
    "status": "found",
    "value": true,
    "source": "derived_from_crl_context",
    "confidence": 0.7,
    "tier": 2
  },
  "prior_crl_reason": {
    "status": "found",
    "value": "Multiregional trial with US population required",
    "source": "web_search",
    "category": "CLINICAL_DATA",
    "confidence": 0.9,
    "tier": 2
  },
  "is_resubmission": {
    "status": "found",
    "value": 1,
    "source": "legacy_v12",
    "confidence": 0.75,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": null,
    "error": null
  },
  "pai_passed": {
    "status": "found",
    "value": true,
    "source": "derived_from_crl_reason",
    "confidence": 0.85,
    "tier": 2
  },
  "warning_letter": {
    "status": "found",
    "value": false,
    "source": "derived_from_crl_reason",
    "confidence": 0.75,
    "tier": 2
  },
  "result": "crl",
  "data_quality_score": 0.075,
  "collected_at": "2026-01-09T00:31:58.806487",
  "enriched_at": "2026-01-11T18:57:55.886868",
  "needs_manual_review": false,
  "review_reasons": [],
  "original_case_id": "e8dd1c2bed96",
  "fda_designations": {
    "breakthrough_therapy": true,
    "fast_track": true,
    "priority_review": true,
    "orphan_drug": true,
    "accelerated_approval": false
  },
  "mechanism_of_action": "Multi-kinase inhibitor",
  "adcom_info": {
    "scheduled": false,
    "held": false,
    "outcome": null,
    "vote": null
  },
  "days_to_pdufa": -1351,
  "pdufa_status": "past",
  "risk_tier": "HIGH",
  "days_calculated_at": "2026-01-10T16:59:39.827426",
  "is_single_arm": {
    "value": true,
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "interventionModel=SEQUENTIAL",
      "allocation=NON_RANDOMIZED"
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-11T08:31:18.779534",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "trial_region": {
    "value": "global",
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "countries=['UNITED STATES', 'ITALY']..."
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-11T08:31:18.779558",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "adcom_scheduled": {
    "value": false,
    "status": "confirmed_none",
    "source": "websearch_adcom",
    "confidence": 0.7,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:38:54.743706"
  },
  "adcom_vote_ratio": {
    "value": null,
    "status": "not_applicable",
    "source": "websearch_adcom",
    "confidence": 0.6,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:38:54.743714"
  },
  "breakthrough_therapy": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T18:57:43.036359",
    "search_status": "CONFIRMED_NONE"
  },
  "orphan_drug": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "HUTCHMED - U.S. FDA Accepts Filing of HUTCHMED’s NDA for ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T18:57:44.058930",
    "search_status": "FOUND"
  },
  "priority_review": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Chi-Med’s New Drug Application for Surufatinib in Non ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T18:57:48.552848",
    "search_status": "FOUND"
  },
  "fast_track": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Chi-Med Announces Surufatinib Granted U.S. FDA Fast Track ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T18:57:49.745244",
    "search_status": "FOUND"
  },
  "accelerated_approval": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T18:57:55.886852",
    "search_status": "CONFIRMED_NONE"
  }
}